Cell/Gene Tx channel feed

Re­genxBio runs in­to par­tial hold for an­ti-VEGF gene ther­a­py as FDA in­ves­ti­gates de­liv­ery de­vice

6 years ago
FDA+

Ther­mo Fish­er hooks gut on­to its gene ther­a­py pipeline, inks new col­lab­o­ra­tion pact

6 years ago

No­var­tis takes a hit as FDA or­ders a hold on Zol­gens­ma tri­als in wake of fresh safe­ty con­cerns

6 years ago
Pharma
FDA+

Sean Park­er helps cre­ate a CRISPRed cell ther­a­py 2.0 play — and he’s got a high-pro­file set of lead­ers on the team

6 years ago
Financing
Startups

Ex­clu­sive: GSK’s Hal Bar­ron al­lies with Rick Klaus­ner’s $600M cell ther­a­py start­up, look­ing to break new ground blitz­ing sol­id tu­mors

6 years ago
Deals

Ness Berming­ham looks to lead the wave of RNA edit­ing at new At­las up­start Ko­r­ro Bio

6 years ago
Startups

Ear­ly func­tion­al da­ta on limb gir­dle pa­tients buoy ex­pec­ta­tions for Sarep­ta's gene ther­a­py

6 years ago
R&D

Re­gen­eron dou­bles down on part­ner Adicet's gam­ma delta T cell tech in $80M fi­nanc­ing

6 years ago
Financing

San Fran­cis­co biotech has its heart in heart fail­ure — and $92M in the bank

6 years ago
Startups

ARC-T? Al­ter­na­tive CAR-T start­up bags $85M for clin­i­cal quest to redi­rect 'blind hunter' T cells

6 years ago
Startups

Neoanti­gen play­er PACT Phar­ma woos Tim Moore from Kite to run tech­ni­cal ops

6 years ago
People

The time is now: John Cox as­sumes CEO post at Flag­ship-backed Torque, steer­ing cell ther­a­py to clin­i­cal tri­als

6 years ago
People

Reg­u­la­tors throw up an­oth­er hur­dle to Roche’s $4.3B Spark ac­qui­si­tion as ques­tions per­co­late over he­mo­phil­ia mar­ket dom­i­na­tion

6 years ago
Deals

No­var­tis ac­cus­es 2 AveX­is founders of al­ter­ing da­ta, stonewalling probe — but ex-CSO blasts back

6 years ago
Pharma
FDA+

Zol­gens­ma did­n't cause an in­fant death, AveX­is ex­ecs say as they spot­light long-term da­ta

6 years ago
R&D
Pharma

'Dis­con­nect the bas­tard­s' — one biotech's plan to break can­cer cell­s' uni­fied de­fens­es

6 years ago
R&D

Ear­ly snap­shot of Ad­verum's eye gene ther­a­py sparks con­cern about vi­sion loss

6 years ago
R&D

Ital­ian gene ther­a­py play­er draws new in­vestor from Chi­na for its an­swer to CAR-T re­laps­es

6 years ago
Financing

A new play­er jumps in­to the heat­ed race for a sick­le cell cure, with help from Google's GV

6 years ago
R&D

Lon­don's 4BIO Cap­i­tal un­veils first close of $150M fund ded­i­cat­ed to ad­vanced ther­a­pies

6 years ago
Financing

Plot­ting clin­i­cal en­try, James Wilson's gene ther­a­py start­up brings in bil­lion­aire for $110M Se­ries B

6 years ago
Financing

Nkar­ta maps out clin­i­cal, man­u­fac­tur­ing plans for CAR-NK fol­low­ing $114M round led by Sam­sara

6 years ago
Financing
Startups

Syn­cona dives deep in­to dry AMD R&D, up­ping Gy­ro­scope bet to $100M

6 years ago
Financing
R&D

Im­mat­ics scores $75M up­front in TCR deal with Cel­gene as in­ter­est in tech bur­geons

6 years ago
Deals
First page Previous page 49505152535455 Next page Last page
A service from the Financial Times